Important information for readers of this Annual Report
For more information in relation to the inclusion of reported performance, Core financial measures and constant exchange rate (CER) growth rates as used in this Annual Report, please see the Financial Review on page 64 of the downloadable PDF. Throughout this Annual Report, growth rates are expressed at CER unless otherwise stated.
The Glossary and the Market definitions table from page 247 of the downloadable PDF are intended to provide a useful guide to terms and AstraZeneca’s definitions of markets, as well as to acronyms and abbreviations, used in this Annual Report.
Use of terms
In this Annual Report, unless the context otherwise requires, ‘AstraZeneca’, ‘the Group’, ‘we’, ‘us’ and ‘our’ refer to AstraZeneca PLC and its consolidated entities.
Cautionary statement regarding forward-looking statements
A cautionary statement regarding forward-looking statements and other essential information relating to this Annual Report can be found on page 251 of the downloadable PDF or in our Cautionary Statement page.
The following sections make up the Directors’ Report, which has been prepared in accordance with the requirements of the Companies Act 2006:
- Corporate Governance Report
- Audit Committee Report
- Development Pipeline
- Responsible Business
- Shareholder Information
- Corporate Information
The following sections make up the Strategic Report, which has been prepared in accordance with the requirements of the Companies Act 2006:
- AstraZeneca at a glance
- Chairman’s Statement
- Chief Executive Officer’s Review
- Therapy Area Review
- Business Review
- Resources Review
- Financial Review